Poolbeg team boosted by highly experienced executives with track record of success 9 November 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces the appointment of key former executives of Amryt Pharma plc (‘Amryt’) to its leadership team. Read more…
New Professional Network for Female Executives and Specialists to Elevate and Promote Female Talents across the Life Sciences industry in Denmark Supported by the Novo Nordisk Foundation Women in Life Science Denmark (WiLD), an inspiring and science-centric not-for-profit network for women in senior positions across industry and academia launched in January 2023 to strengthen value creation in […]
BERLIN, 7 July 2022 – Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat cancers, is pleased to announce the appointment of Serge Sagodira as Chief Business Officer. Appointed from 1 July 2022, Serge will oversee all business development aspects of the company, leveraging […]
The leading European central nervous system specialty company expands its operations in the highly attractive Swiss market and introduces Jörg Gärtner as new country manager Dusseldorf and Liestal, May 3, 2022 – Neuraxpharm Group (Neuraxpharm) ignites the next level of their business in Switzerland to leverage the full potential of the important pharmaceutical market. After having […]
Brings in-depth R&D expertise in oncology, including ADCs, targeted radiotherapies, immunooncology and small molecules Adcendo building a world class team of experienced biotech & pharma executives and renowned leaders in the ADC field Copenhagen, Denmark, May 3, 2022 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the […]
